Uridine

DB02745ApprovedWithdrawnSmall moleculePyrimidine Analog

Uridine is a drug used to manage neuropsychiatric deficits associated with cerebrovascular diseases in combination with cytidine. A drug used to treat a decline in brain functions caused by various brain disorders.

Formula / weight: C₉H₁₂N₂O₆ · 244.2014 g/mol (avg)

Resolves to

Compound

UNIIWHI7HQ7H85CAS58-96-8ChEMBLCHEMBL100259ChEBI16704PubChem6029KEGGC00299

Clinical / RWD

RxNorm11017PharmGKBPA130230921

Structure

InChIKeyDRTQHJPVMGBUCF-XVFCMESISA-NSMILESOC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(=O)NC1=O

Targets

P19971TYMPP62312LSM6P0A927tsx

Transporters

Q99808SLC29A1

What you can answer from here — as of September 12, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1TransporterSubstrate / inhibitor direction, not just membership

Listed above

14Clinical trialsPhase, status and sponsor resolved per trial

1Structured indicationCondition, population, route and combination as fields, not prose

1ContraindicationEach with its own population and attribute set

6Marketed productsAcross 1 country and 1 labeller

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with Uridine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account